CA1309661C - Systeme d'administration transdermiques - Google Patents

Systeme d'administration transdermiques

Info

Publication number
CA1309661C
CA1309661C CA000565125A CA565125A CA1309661C CA 1309661 C CA1309661 C CA 1309661C CA 000565125 A CA000565125 A CA 000565125A CA 565125 A CA565125 A CA 565125A CA 1309661 C CA1309661 C CA 1309661C
Authority
CA
Canada
Prior art keywords
composition
weight percent
procaterol
barrier membrane
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000565125A
Other languages
English (en)
Inventor
Susan C. Moniot
Niranjan M. Patel
Mohan B. Kabadi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of CA1309661C publication Critical patent/CA1309661C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CA000565125A 1987-07-31 1988-04-26 Systeme d'administration transdermiques Expired - Fee Related CA1309661C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US079,965 1987-07-31
US07/079,965 US4788064A (en) 1987-07-31 1987-07-31 Transdermal delivery system

Publications (1)

Publication Number Publication Date
CA1309661C true CA1309661C (fr) 1992-11-03

Family

ID=22153943

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000565125A Expired - Fee Related CA1309661C (fr) 1987-07-31 1988-04-26 Systeme d'administration transdermiques

Country Status (7)

Country Link
US (1) US4788064A (fr)
EP (1) EP0301589B1 (fr)
JP (1) JPS6442432A (fr)
AT (1) ATE94769T1 (fr)
CA (1) CA1309661C (fr)
DE (1) DE3884309T2 (fr)
ES (1) ES2043744T3 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3844247A1 (de) * 1988-12-29 1990-07-12 Minnesota Mining & Mfg Vorrichtung, insbesondere pflaster zum transdermalen verabreichen eines medikaments
AU653156B2 (en) * 1990-06-14 1994-09-22 Dermamed Transdermal administration to humans and animals
KR920703033A (ko) * 1990-11-09 1992-12-17 아카자와 소조 프로카테롤을 함유한 외용제
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
IT1261849B (it) * 1993-09-02 1996-06-03 Avantgarde Spa Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
TW396350B (en) * 1996-12-04 2000-07-01 Nat Science Council Dielectric composition, slurry for use in the tape casting process, porcess for producing a ceramic product and process for preparing multilayer ceramic package
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
KR101159828B1 (ko) 2003-04-30 2012-07-04 퍼듀 퍼머 엘피 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
DE102004062614B4 (de) * 2004-12-24 2011-12-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung
WO2011022371A2 (fr) * 2009-08-17 2011-02-24 Silipos Inc. Produit en gel

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
JPS6045522B2 (ja) * 1982-12-08 1985-10-09 憲司 中村 化粧用具
FR2547502B1 (fr) * 1983-06-15 1986-05-16 Dexo Lab Pharma Matrice pour la diffusion continue et progressive d'un principe actif par voie transcutanee
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
ZA853488B (en) * 1984-05-10 1986-12-30 American Home Prod Transdermal dosage form
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
ZA875317B (en) * 1986-08-01 1988-01-25 Warner-Lambert Company Transdermal compositions
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
EP0375689B1 (fr) * 1987-06-01 1992-08-12 Warner-Lambert Company Composition pharmaceutique adaptee a l administration transdermique d'un medicament opioid.

Also Published As

Publication number Publication date
EP0301589B1 (fr) 1993-09-22
DE3884309D1 (de) 1993-10-28
EP0301589A3 (en) 1989-07-12
ES2043744T3 (es) 1994-01-01
DE3884309T2 (de) 1994-01-20
JPS6442432A (en) 1989-02-14
US4788064A (en) 1988-11-29
ATE94769T1 (de) 1993-10-15
EP0301589A2 (fr) 1989-02-01

Similar Documents

Publication Publication Date Title
JP3228341B2 (ja) 塩基性薬物を経皮的に送達するための透過増強剤としてのトリアセチン
US5122383A (en) Sorbitan esters as skin permeation enhancers
KR930001082B1 (ko) 피부 또는 점막에 유효약제의 투여장치
US4789547A (en) Transdermal matrix system
TWI435737B (zh) 經皮遞送醫藥化合物的方法及其組成物
KR100267442B1 (ko) 아세틸살리실산을 함유하는 혈전증 치료용 및 암 예방용 경피적 투여시스템
JP2604097B2 (ja) 皮膚浸透増強剤としてソルビタンエステルを用いた経皮的に薬物を投与するための方法およびシステム
KR960005142B1 (ko) 활성 성분으로서 툴로부테롤을 함유하는 경피성 치료 시스템
US5227169A (en) Sorbitan esters as skin permeation enhancers
US20020176887A1 (en) Methods of delivery of cetyl myristoleate
US4910205A (en) Transdermal delivery of loratadine
JPS5822057A (ja) 新規包帯による治療系
JP2003532629A (ja) 第４アンモニウム塩の経皮薬剤放出への使用
JPH0575727B2 (fr)
JP2000517343A (ja) 医薬の塩を経皮送達するための感圧接着剤マトリックスパッチ
EP1027889B1 (fr) Dérivés de l' Ergolin à application transdermique
CA1309661C (fr) Systeme d'administration transdermiques
US5212199A (en) Sorbitan esters as skin permeation enhancers
ES2273042T3 (es) Sistema mejorado de suministro transdermico.
CN106361728B (zh) 经皮吸收制剂及制备经皮吸收制剂的方法
US20050232983A1 (en) Transdermal patch
KR950013448B1 (ko) 경피 투여형 약물용 첩포(貼布)제
FI120719B (fi) Menetelmä asetyylisalisyylihappoa sisältävän transdermaalisen järjestelmän valmistamiseksi
JP2003511407A (ja) 座瘡関連の病気の治療のためのアセチルサリチル酸の局所適用のための表面治療システム
CN1226163A (zh) 治疗和/或预防痴呆的制剂

Legal Events

Date Code Title Description
MKLA Lapsed